UNIVERSITY OF KENTUCKY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1865-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uky.edu
Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 380
- Registration Number
- NCT00255931
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2012-05-23
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 100
- Registration Number
- NCT00237575
- Locations
- 🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸University of Nebraska, Omaha, Nebraska, United States
🇺🇸New York Medical College, Hawthorne, New York, United States
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-06-18
- Lead Sponsor
- University of Kentucky
- Registration Number
- NCT00176280
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 2
- Registration Number
- NCT00176293
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Mood and Behavior Changes Among Overweight Adolescent Females
Withdrawn
- Conditions
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- University of Kentucky
- Registration Number
- NCT00127374
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
- First Posted Date
- 2004-02-20
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 25
- Registration Number
- NCT00003425
- Locations
- 🇺🇸
Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States
🇺🇸Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath